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Obesity is a known risk factor for many types of cancer including pancreatic.  Calorie 
restriction (CR), an anti-obesity diet regimen, has potent anticancer effects that may be 
mediated through its ability to reduce serum metabolic hormones and protumorigenic 
cytokines such as insulin-like growth factor (IGF)-1. IGF-1 is a metabolic hormone 
responsive to nutrient status that activates the inflammatory, cancer-related pathway, 
nuclear factor (NF)-кB.  For this report, we tested the hypothesis that CR, via regulation 
of IGF-1, inhibits pancreatic tumor cell growth through modulation of NF-kB activation 
and protumorigenic gene expression.  Male athymic nude mice were randomized to either 
a control diet consumed ad libitum (n=15) or a 30% CR diet (n=15) for 17 weeks, at 
which time, mice were injected with human pancreatic cancer cells (MiaPaca) and tumor 
growth was monitored for 6 weeks. Translocation of p65, a regulatory element of NF-kB, 
and expression of its downstream gene targets were analyzed in excised tumors. CR mice 
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weighed less, (p<0.05), and had smaller tumors (p=0.022) relative to controls.  Tumors 
from CR mice, relative to controls, demonstrated significant decreases in NF-kB 
downstream genes CCND1, RELA, Survivin, VEGF, and XIAP. These findings parallel 
our previous studies in pancreatic tumors from mouse origin, and suggest that the 
inhibitory effects of CR on MiaPaca pancreatic tumor growth are associated with 
decreased NF-kB activation. 
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Chapter 1:  INTRODUCTION 
Pancreatic ductal adenocarcinoma is the 4th leading cause of cancer mortality in 
the U.S [1]. Only 4% of diagnosed individuals survive beyond 5 years.  Because 
pancreatic cancer is generally diagnosed in an advanced stage, as a result of minimal 
symptoms and lack of palpable tumor, survival rate is extremely low.  Although little is 
known regarding the etiology of pancreatic cancer, epidemiologic evidence has recently 
established a significant link to obesity [2].  Obesity is particularly problematic in that it 
creates an ideal environment for tumor development and progression, including,increased 
blood glucose and insulin resistance which in turn lead to dysregulation of the hormones 
insulin, leptin, and IGF-1 [3, 4].  Additionally, obesity induces a state of chronic 
inflammation, which is associated with cancer promoting gene expression [5].  The 
prevalence of obesity is rapidly increasing in the U.S.  Currently, 33.8% of all American 
adults are obese, and 68% are overweight [6]. Overweight and obese individuals are at 
increased risk for a number of health issues including insulin resistance, leptin resistance, 
heart disease, stroke and some cancers [7]. It is estimated that 90,000 cancer-related 
deaths could be prevented per year with the maintenance of normal body weight [1]. 
Additionally, both men and women are at greater risk or mortality from all cancers when 
compared to those of normal weight despite whether or not they smoke cigarettes [8, 9].  
Calle et al. stress the strong link between obesity and cancer risk, but the underlying 
mechanisms are not well understood.   
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As mentioned, obesity promotes the dyeregulation of cancer related hormones, 
specifically leptin, adiponectin, insulin, and IGF-1 [10]. Insulin is produced by the beta 
cells of the pancreas in response to a raise in blood glucose.  Elevated circulating insulin 
due to feeding results in increased glucose uptake in tissues such as adipocytes and 
muscle and enhances energy production or storage. The peptide hormone, leptin, is 
secreted by the adipocytes in response to insulin, and acts as an indicator of peripheral fat 
mass which is crucial for the regulation of satiety. In an obese state, tissues become less 
responsive, or resistant to these hormones.  Similarly, circulating free IGF-1 levels are 
positively correlated with body mass index (BMI).  High IGF-1 levels are observed in 
prostate, breast, colon and pancreatic cancers [11], and treatment with IGF-1 results in 
cancer promoting events such as proliferation and increased cell survival in multiple cell 
lines in vitro [12-14]. 
Not only does obesity promote these hormonal responses, it also produces a state 
of chronic low-grade inflammation [3]. Links between chronic inflammation and cancer 
are effectively demonstrated by the 53 percent increased risk of pancreatic cancer 
development in individuals who suffer from chronic hereditary pancreatitis [11, 15, 16].  
Transcription factor, NK-kB is activated by inflammation through transcriptional 
regulation of various cancer promoting genes including those responsible for 
angiogenesis, cell proliferation, cell cycle regulation, apoptosis, and inflammation.  NF-
kB is commonly upregulated in many cancers, including 70 percent of pancreatic cancer 
cell lines.  Harvey et al. found that NF-kB is modulated in response to elevated IGF-1 in 
vitro as well as in an in vivo transplant model of colon cancer [12]. Proinflammatory 
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stimuli, such as increased IGF-1 levels resulting from obesity, can activate NF-kB by 
targeting the inhibitory subunit IkBα for ubiquitination, thus freeing NF-kB to translocate 
to the nucleus where it can transcribe these cancer promoting genes [17, 18].   
Calorie Restriction (CR) has been shown to exert substantial anticancer effects in 
many models of cancer, in part through its regulation of circulating levels of insulin, 
leptin, IGF-1, and adiponectin.  From our lab, Lashinger et al. and Harvey et al. showed 
that CR significantly decreased pancreatic tumor growth in both syngeneic transplant and 
transgenic models of pancreatic cancer [10, 12, 19].  It is established that CR works 
through a variety of ways [20]. Lashinger et al. suggested that CR is effective through 
reductions in IGF-1 [10], and furthermore, Harvey et al. suggest that manipulations of 
IGF-1 work partially through modulation of NF-kB.  Harvey et al. additionally 
demonstrated significantly lower levels of p65 (NF-kB subunit) staining in colon cancer 
tumor sections of mice on a CR regimen, as well as decreased levels of macrophage 
markers, and NF−κB downstream genes [12].  This has not, however, been demonstrated 
in the MiaPaca human pancreatic cancer cell line. Thus we hypothesized that CR will 
inhibit pancreatic tumor cell growth as a result of diminished NF-kB activity leading to 










Chapter 2:  MATERIALS AND METHODS 
 
2.1 Animals and Diets 
Male Athymic Nude mice were purchased from Jackson Laboratories, (Bar 
Harbor, ME) and placed on chow diet for one week following arrival.  Mice, 
(n=15/group) were randomized to receive either a control diet (#D0302702, Research 
Diets, New Brunswick, NJ) or an isonutrient 30% CR diet (#D03022702), administered 
as a daily aliquot of 70% of the daily amount consumed by the control group, resulting in 
a lean phenotype.  Animals were singly housed and received diet beginning at 7 weeks of 
age for 23 weeks.  Food intake and body weights were recorded weekly throughout the 
duration of the study.  The same protocol was followed for the preliminary Panc02 study. 
2.2 MiaPAca Tumor Cell injections 
At week 17 of diet treatment, mice were subcutaneously injected with 4,000,000 human 
pancreatic cancer cells (MiaPaca) in the right flank.  Diet regimens were continued until 
sacrifice at week 23.  Following tumor implantation, tumor dimensions were recorded 
following palpation with Vermeer calipers bi-weekly.  Following 6 weeks of tumor 
growth, mice were sacrificed when the majority of the tumors reached 1.5 cm in 
diameter.  Sacrifice was executed by CO2 asphyxiation followed by cervical dislocation. 
Final tumor volume was calculated from 3 dimensions measured on excised tumors using 
the formula 4/3п((r1)(r2)(r3)).  Tumors were then flash frozen in liquid nitrogen, and 
stored at -80°C or fixed in 10% neutral-buffered formalin overnight then switched to 
ethanol until paraffin embedding.  Prior to injection MiaPaca cells were maintained in 
incubation conditions as previously described in media solution of DMEM (Invitrogen, 
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Carlesbad CA), 10,000 U/mL penicillin, 10,000U/mL of streptomycin, 1X Non Essential 
Amino Acids, 10mM HEPES buffer, and 1mM sodium pyruvate.  Injections were on the 
left flank of each animal. The same protocol was followed for the preliminary Panc02 
study, but with male C57B6 mice injected with 100,000 cells. 
2.3 Real-time PCR 
 Gene expression of RELA, VEGFA, Cyclin D1, XIAP, and Survivin were 
determined through PCR using TaqMan primer-probes (Ambion, Austin TX), and 
normalized to β-actin in MiaPaca tumors following RNA extraction and reverse 
transcription.  Total RNA was extracted using the Qiagen RNeasy Mini Kit following the 
Qiagen protocol (Qaigen CA).  2 ug of RNA was reverse transcribed using a high 
capacity cDNA Reverse Transcription kit (Ambion, Austin TX).  Analysis was 
performed using the delta-delta CT method.   
2.4 Immunohistochemimical (IHC) Staining of phospho p65 
Tissue blocks were deparaffinized in xylene and then rehydrated in ethanol to 
water for IHC analysis.  Endogoenous peroxidase activity was blocked with 3% H202 in 
water for 10 minutes, and then washed.  Antigen retrieval was performed with 10mM 
citrate buffer for 3 minutes at 100% power, and 15 minutes at 50% power in a 
microwave, followed by cooling for 20 minutes.  Biocare blocking reagent (Biocare, 
catalog #BS977M, BS966M, Concord, CA) was incubated with slides for inhibition of 
non-specific antibody.  Slides were then incubated with primary phospo p65 antibody 
(#3033, Cell Signagling, Boston, MA, #sc 101749, Santa Cruz Biotechnology, Santa 
Cruz, CA (human)) at 1:100 dilution for 8 hours.  Slides were incubated with Dako 
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EnVision labeled polymer, anti-rabbit-HRP (catalog #K400, Carpinteria, CA), Dako 
diaminobexidine and counterstained with hematoxylin.  Assessment of nuclear versus 
cytoplasmic staining was conducted by 2 independent blinded observers.  
 
2.5 Statistics 
All values are shown as + standard error of the mean unless otherwise noted. 
Statistical Package for the Social Sciences (SPSS) was used for statistical analysis.  
Differences in body weight over time between CR and control groups were assessed 
using repeated measured; differences in final tumor measures and gene expression were 














Chapter 3:  RESULTS 
3.1 Preliminary Panc02 Data 
Diet significantly affected pancreatic tumor growth in C57BL/6 mice.  
Measurements taken 4 weeks after injection showed that the CR group had smaller 
tumors compared to control (Figure 1A).  This finding was confirmed by ex vivo 
measurements of final tumor volume (Figure 1B). Analysis of inflammatory gene 
expression showed tumors from CR mice, relative to controls (n=3 mice/group), 
displayed up to a 71% decrease in the inflammatory markers, S100a9 and F4/80 (p<0.05 
for each; Figure 1C) and a 56% decrease in the macrophage chemoattractant Ccl2 (gene 
























Figure 1:  Effect of diet on Panc 02 tumor volume, and proinflammatory gene expression 
(Harvey dissertation, 2011)  
Calorie restriction (CR) decreased tumor growth and overall median tumor volume 
compared to control-fed (CON) mice.  (A) Average tumor volume in vivo, data shown 
mean + SE, significance (p<0.05) between groups; (B) Median final tumor volume ex 
vivo, significance (p<0.003) between groups.  (C) Calorie restriction (CR) modulates 
proinflammatory gene expression within the tumor microenvironment compared to 
control (CON) mice.  All data represent CR gene expression relative to CON.  Values are 
mean + SE (n=3/group). Significance (p<0.05) between groups is denoted by *. 



































































3.2 CR reduced body weight and tumor volume of male athymic mice  
 
 CR mice weighed significantly less than mice on control diet beginning at week 
three. An average 13g difference remained throughout the study (p<0.05; Fig. 8) (for 
clarity purposes body weight was graphed every 4 weeks). 
 
Figure 2:  Effect of diet on body weight in male athymic nude mice 
 
Calorie restriction (CR) decreased body weight and percent body fat relative to control 
(CON) ad libitum fed diet. Average body weight of mice fed a CR or CON diet (body 
weight graphed every 4 weeks for clarity purposes) All data shown are mean + SD 
(n=15/group). Significance (p<0.05) is denoted by *. 
 
 
3.3 CR Reduced MiaPaca Pancreatic Tumor Volume  
  
 Diet significantly affected pancreatic tumor growth in athymic nude mice. CR 
reduced tumor surface area as compared to control (data not shown).  CR significantly 
reduced final tumor volume, measured ex vivo, relative to control mice (83 and 53 mm3, 
respectively, p=0.022; Fig. 2).    
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Figure 3: Effect of diet on MiaPaca tumor volume  
 
The median final tumor volume ex vivo, was significantly smaller in the CR group 
compared to control (significance (p<0.022) between groups). 
 
3.4 CR reduced p65 and inflammatory gene expression in MiaPaca tumors 
 
 Histological analysis of the tumors harvested from CR (n=8) and control (n=10) 
(samples limited to tissue availability) demonstrated a trend toward lesser nuclear p65 
staining in control compared to CR tumors, but values were not statistically significant 
(p=.07).  The profile of inflammatory gene expression demonstrated that tumors from CR 
mice, relative to controls (n=6 mice/group), had significantly lower expression of NF-kB 
downstream genes Ccnd1 (1.8 fold decrease), Birc5 (8 fold decrease), VegfA (10 fold 
decrease), and Xiap (50 fold decrease).  A Significant decrease in RelA (6 fold decrease), 
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the gene encoding for the p65 subunit was also observed.  (p<0.05 for each; Fig. 3) 
 
Figure 4:  Effect of diet on NF-kB downstream genes in MiaPaca Tumors 
 
Calorie restriction (CR) modulated downstream gene expression within the tumor 
microenvironment compared to control (CON) mice.  All data represents CR gene 
expression relative to CON.  Values are mean + SE (n=6/group). Significance (p<0.05) 






















Chapter 4:  DISCUSSION 
 
It is well established that CR can effectively decrease inflammatory signals.  
Moreover, the links between CR, systemic hormones, and NF-kB, have been 
demonstrated in our lab in a transplant model of colon cancer.  Tumors from CR mice 
demonstrated decreased expression of the proinflammatory cytokines, IL-6 and IL-1B 
and TNF-a, and the inflammatory enzyme COX-2; and increased the antiinflammatory 
enzyme Hpgd.  Nuclear localization of the p65 subunit was also elevated following 
treatment with IGF-1 [14].  In preliminary studies in the mouse pancreatic cancer cell line 
Panc02, it was found that CR, relative to control fed mice, significantly reduced body 
weight, body fat, and effectively modulated serum hormones.  Additionally, treatment 
with IGF-1 increased cell viability and nuclear translocation of NF-kB.  On the other 
hand, silencing NF-kB activity with siRNA led to decreased expression of Cyclin D1, 
VegfA, Birc5, and Cox-2.  Though CR has been shown to inhibit the expression of 
inflammatory markers [3, 21, 22], body weight, and tumor volume and growth, this had 
not previously been demonstrated using pancreatic cancer models.   
In order to determine that the observed effects of CR are maintained in a human 
pancreatic cancer cell line, the MiaPaca cell line was used for this study.  Paralleling our 
previous study of Panc02 transplant tumors, CR indeed led to lower body weight, and 
final tumor volume compared to mice on control diet.  Similarly, decreased expression of 
the p65 subunit and NF-kB downstream genes was observed in tumor sections excised 
from these mice.  NF-kB subunit, p65 is phosphorylated when fully activated, and 
analysis of tumor sections revealed a trend of less phospho-p65 in the nucleus in CR 
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tumor sections compared to sections taken from CR tumors.  Though not statistically 
significant, these findings suggest that the CR decreases nuclear translocation of the p65 
subunit, and thus minimizes NF-kB-induced gene transcription of proinflammatory 
mediators.   
This research further defined our lab’s investigation of the mechanisms through 
which CR reduces tumor burden [20].  We have demonstrated this in transgenic as well 
as several transplant models in the breast and the pancreas [10, 23-25].  Calorie 
restriction is a multifaceted intervention, and as low-grade, chronic inflammation 
becomes a better-understood player in tumorgenesis and progression, this research 
becomes increasingly important in narrowing our understanding.  Pancreatitis is an 
established risk factor for pancreatic cancer, and highlights the need for development of 
early intervention targeting the inflammatory state for prevention [26-28].  In conclusion, 
this study shows that CR, and subsequent reductions in IGF-1, inhibits growth in both 
human and mouse pancreatic tumors, in part, though reduction in NF-кB-induced 
proinflammatory gene expression (Figure 5).  Future studies will investigate the effects of 
obesity reversal, and the effects on final tumor burden in comparison to animals 




Figure 5:  Model of IGF-1 induced chances in NF-kB signaling 
In response to stimuli, such as elevated circulating IGF-1, IKKb activation targets 26S 
proteasomal degradation of IkBa though phosphorylation of IkBa. Degradation of IkBa 
relieves the cytosolic sequestration of NF-kB subunits and allows for nuclear 
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